KAKátia Ávila Antunes

Kátia Ávila Antunes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kátia Ávila Antunes has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Edson Lucas dos Santos

    Research Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM), Universidade Federal da Grande Dourados, Dourados-Itahum Highway, Km 12, Dourados 79804-970, MS, Brazil

    2 shared publications
  • Eliana Janet Sanjinez-Argandoña

    School of Engineering (FAEN), Federal University of Grande Dourados (UFGD), Dourados, Brazil

    2 shared publications
  • Kely de Picoli Souza

    Research Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM), Faculdade de Ciências Biológicas, Universidade Federal da Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil

    2 shared publications
  • Alex Santos Oliveira

    Research Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM), Faculdade de Ciências Biológicas, Universidade Federal da Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil

    1 shared publication
  • Alércio da Silva Soutilha

    Research Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM), Faculdade de Ciências Biológicas, Universidade Federal da Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil

    1 shared publication
  • Carlos Alexandre Carollo

    Laboratory of Natural Products and Mass Spectrometry—LaPNEM, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Anemopaegma arvense Leaf Extract Attenuates Lipid Accumulation in Adipocytes, and Caenorhabditis elegans, and Reduces Weight Gain and Hypertriglyceridemia in Rats

    by Debora da Silva Baldivia, Kátia Ávila Antunes, Alércio da Silva Soutilha, Wellington Henrique Botelho, Matheus Henrique Franco Alves, Sarah Lam Orué, Helder Freitas dos Santos, Alex Santos Oliveira, Daniel Ferreira Leite, Pedro Henrique Patrício Barbosa, et al.

    Background: Obesity and hypertriglyceridemia are complex metabolic conditions that arise from the expansion of white adipose tissue and dysfunction in lipid metabolism. Given the limitations of conventional therapies, plant-derived extracts have been investigated as promising alternative strategies. Objectives: The present study aimed to characterize the phytochemical profile of the hydroethanolic extract from Anemopaegma arvense leaves (HEAa), assess its toxicological safety, and investigate its effects on metabolic phenotype safety related to lipid accumulation using complementary biological models. Methods: HEAa was chemically characterized by LC-DAD-MS, and its toxicological profile was assessed using complementary in vitro, ex vivo, and in vivo models. Its effects on lipid-related metabolic phenotypes were assessed in adipocytes, Caenorhabditis elegans, and Wistar rats with high-fructose diet (HFrD)-induced body-weight gain and hyperlipidemia after 70 days of treatment. Results: HPLC-DAD-MS analysis revealed a chemically diverse profile composed mainly of flavonol glycosides, hydroxycinnamic acid derivatives, lipid-derived compounds, triterpenoids, megastigmane glycosides, and pheophorbide a; rutin was confirmed by comparison with an authentic standard. HEAa showed no hemolytic activity in human erythrocytes and did not reduce viability in C. elegans under the tested conditions. In 3T3-F442A adipocytes and C. elegans, HEAa produced modest reductions in neutral lipid accumulation. In high-fructose-fed Wistar rats, repeated HEAa administration reduced body-weight gain by approximately 53% and serum triglycerides by approximately 56% compared with untreated high-fructose-fed animals. Increases in ALT and AST levels were observed following prolonged exposure. Conclusions: HEAa modulated lipid accumulation and obesity-related metabolic phenotypes across complementary experimental models, with effects on body-weight gain and hypertriglyceridemia in rats fed a high-fructose diet. These findings support further investigation of A. arvense as a botanical candidate for metabolic disorders, nevertheless, the increases in hepatic enzymes highlight the need for additional studies to define its long-term safety.

  • Open Access

    The Chemical Composition and Metabolic Effects of Attalea phalerata Nut Oil in Hyperlipidemic Rats Induced by a High-Fructose Diet

    by Débora Da Silva Baldivia, Eliana Janet Sanjinez-Argandonã, Kátia Ávila Antunes, Izabel Cristina Freitas Moraes, Edson Lucas Dos Santos, Kely De Picoli Souza

    The fatty acids found in nuts are important regulators of the metabolism. These acids are frequently associated with a reduction of serum cholesterol and body fat and a lower risk of developing cardiovascular disease. In this context, the aim of this study was to identify and quantify the nut oil fatty acids from Attalea phalerata and investigate their metabolic effects in rats with hyperlipidemia induced by a diet rich in fructose. Oleic and lauric acids were the major compounds found in the A. phalerata nut oil (APNO). Hyperlipidemic rats treated with APNO showed a reduction in the total serum cholesterol similar to those treated with simvastatin, an increased body temperature by 1 °C, and a reduction in the body weight gain and mesenteric depot of white adipose tissue compared to the hyperlipidemic controls rats. There was an increase in the relative liver weight of rats treated with APNO, without, however, any change in the serum markers of hepatic toxicity. In addition, there was an increase in the moisture and lipid content of the feces of the rats treated with APNO compared to the controls. Together, these results suggest that APNO has potential use in health foods and nutritional supplements to control hypercholesterolemia and obesity.